We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+11.98%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.51B
AUM Growth
+$79.8M
Cap. Flow
-$58.7M
Cap. Flow %
-3.88%
Top 10 Hldgs %
27.14%
Holding
456
New
26
Increased
163
Reduced
145
Closed
50

Top Buys

1
UTHR icon
United Therapeutics
UTHR
+$17.1M
2
TTWO icon
Take-Two Interactive
TTWO
+$15.5M
3
LVS icon
Las Vegas Sands
LVS
+$12.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$12.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$12.1M

Top Sells

1
EA icon
Electronic Arts
EA
+$18.8M
2
BDX icon
Becton Dickinson
BDX
+$18.6M
3
FNV icon
Franco-Nevada
FNV
+$13.2M
4
BIIB icon
Biogen
BIIB
+$11.5M
5
ES icon
Eversource Energy
ES
+$10.7M

Sector Composition

1 Healthcare 33.57%
2 Consumer Staples 28.33%
3 Technology 7.15%
4 Communication Services 6.29%
5 Materials 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$146B
$46.5M 3.08%
906,601
-27,806
-3% -$1.33M
MRK icon
2
Merck
MRK
$325B
$46.2M 3.06%
416,066
-61,245
-13% -$6.26M
GIS icon
3
General Mills
GIS
$21B
$44.4M 2.94%
529,371
+5,231
+1% +$426K
KMB icon
4
Kimberly-Clark
KMB
$36.8B
$42M 2.78%
309,506
-22,456
-7% -$2.85M
CHD icon
5
Church & Dwight Co
CHD
$23.9B
$40.2M 2.66%
498,685
+30,307
+6% +$2.33M
K
6
DELISTED
Kellanova
K
$39.8M 2.63%
594,473
+37,521
+7% +$2.55M
SJM icon
7
J.M. Smucker
SJM
$12.6B
$39.3M 2.6%
248,002
+4,300
+2% +$641K
CLX icon
8
Clorox
CLX
$12.1B
$38M 2.52%
270,860
+194
+0.1% +$27.5K
CPB icon
9
Campbell Soup
CPB
$6.95B
$37.5M 2.48%
661,340
+7,128
+1% +$374K
GEN icon
10
Gen Digital
GEN
$16.4B
$36.1M 2.39%
1,685,760
+66,330
+4% +$1.46M
DGX icon
11
Quest Diagnostics
DGX
$23.6B
$35.8M 2.37%
229,043
-30,800
-12% -$4.43M
HRL icon
12
Hormel Foods
HRL
$14.4B
$35M 2.32%
768,456
+17,851
+2% +$831K
NBIX icon
13
Neurocrine Biosciences
NBIX
$17.3B
$34.4M 2.28%
287,840
+969
+0.3% +$113K
DLTR icon
14
Dollar Tree
DLTR
$25.4B
$33.9M 2.25%
239,977
+36,172
+18% +$5.38M
LLY icon
15
Eli Lilly
LLY
$1.05T
$30.5M 2.02%
83,445
-8,654
-9% -$3.07M
UTHR icon
16
United Therapeutics
UTHR
$22.7B
$30.4M 2.01%
109,284
+67,767
+163% +$17.1M
NEM icon
17
Newmont
NEM
$95.9B
$29.6M 1.96%
626,973
-78,275
-11% -$3.49M
TTWO icon
18
Take-Two Interactive
TTWO
$43.2B
$28.3M 1.87%
271,462
+143,002
+111% +$15.5M
CHRW icon
19
C.H. Robinson
CHRW
$24.2B
$28.2M 1.87%
307,718
-16,751
-5% -$1.59M
ABBV icon
20
AbbVie
ABBV
$460B
$27.6M 1.83%
170,915
+50,459
+42% +$7.74M
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$37.6B
$27.6M 1.83%
116,048
+15,183
+15% +$3.24M
JNJ icon
22
Johnson & Johnson
JNJ
$614B
$25.4M 1.68%
143,858
+71,330
+98% +$12.3M
SLB icon
23
SLB Ltd
SLB
$70.4B
$25M 1.66%
467,766
+49,287
+12% +$2.45M
MRNA icon
24
Moderna
MRNA
$25B
$23.8M 1.58%
132,726
-18,526
-12% -$3.03M
AIZ icon
25
Assurant
AIZ
$13.9B
$23.5M 1.56%
187,936
+18,510
+11% +$2.47M
1
2 3 4 5

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q4 2022 Portfolio in Review

As of Q4 2022, TOBAM held 456 positions worth $1.51B, up 5.6% from $1.43B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM withdrew a net $58.7M in Q4 2022, closing 50 positions and reducing 145 holdings. Its most notable exit was Electronic Arts, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Enerplus Corporation worth $654K.

  • TOBAM's largest Q4 2022 buy was Enerplus Corporation: 36,977 shares worth $654K.
  • TOBAM added most to United Therapeutics in Q4 2022, an estimated $17.1M increase.
  • TOBAM's biggest Q4 2022 reduction was Becton Dickinson, cutting an estimated $18.6M.
  • TOBAM fully exited Electronic Arts in Q4 2022, selling an estimated $18.8M.
  • TOBAM's ten largest holdings make up 27% of its $1.51B portfolio in Q4 2022.
  • TOBAM opened 26 new positions and closed 50 in Q4 2022.
  • TOBAM's portfolio value rose 5.6% quarter-over-quarter to $1.51B.

Based on TOBAM's 13F filing for Q4 2022, filed 2 Feb 2023.